The Placebo Effect Is Real: 6 Studies Exploring How Expectations Relate to Health
Placebo & nocebo research shows expectations change blood pressure, pain, and hormones. 6 studies on how self-talk shapes your health.
Placebo & nocebo research shows expectations change blood pressure, pain, and hormones. 6 studies on how self-talk shapes your health.
Two new 2026 studies: repeat high-dose ketamine infusions gave a third of fibromyalgia patients 2-year relief, while ketamine plus psychotherapy beat ketamine alone.
A specific THC/CBD formulation significantly reduced agitation in hospice-eligible people with advanced dementia during a 12-week Phase 2 trial.
IL-15 and IL-7: the immune markers a new 2026 study looked at beyond the standard inflammation markers (CRP and IL-6), and how they tracked with ketamine response in depression.
New study: 55% of 6,000+ chronic pain patients using medical cannabis reported better quality of life in 4 months. How it compares to NSAIDs and opioids.
An evidence-based look at what GLP-1 medications like Ozempic do beyond weight loss, from heart and kidney protection to addiction. Current as of June 2026.
A March 2026 study published in Molecular Psychiatry uses PET brain imaging to offer a clearer look at how ketamine may rapidly improve symptoms in treatment-resistant depression.
New (May 2026) ASKP3 ketamine guidelines explain IV ketamine induction, maintenance, dosing, and safety for effective depression treatment.
A well-cited UCLA fMRI study shows that labeling an emotion quiets the amygdala and activates the prefrontal cortex, helping the brain regulate anxiety & fear in real time.
Medical marijuana is now Schedule III. Here's what the federal reclassification actually changes for patients, clinicians, and states (it’s not legalization).
This review on IBD and depression explains how the gut-brain loop may drive both inflammation and mood symptoms (and how the gut and brain speak to each other in both directions).
Podcast recap on chronic pain, the nervous system, Pain Reprocessing Therapy, and how medical cannabis may fit into a more individualized treatment plan.
A UC Berkeley study found awe had the most reliable link to lower IL-6 among seven positive emotions.
A study published in JAMA in March of 2026 says psychedelics are no better than antidepressants for depression. Here’s why the headline misses key context on side effects, duration, and healing.
Ketamine dosing explained: IV, IM, intranasal, and oral routes compared: bioavailability, clinical research, and how dosing decisions are made.
New JAMA study: ~100 minutes of daily walking (no matter the speed) is linked to lower chronic low back pain risk and better longevity outcomes.
A summary of our 3-patient case series in Frontiers in Pain Research: low-dose ketamine plus PRT/somatic tracking, IFS/EMDR, breathwork & movement.
The Window of Tolerance explains how much stress and emotion your body can handle before tipping into overwhelm or shutdown.
Your body budget tracks energy like a bank account. When it runs low, your mood and health suffer.
Stanford Medicine' talk summary: why women’s pain differs across life stages, the role of hormones/nervous system, and practical, evidence-informed care takeaways.